PREVENTION

How to eliminate gastric cancer-related death worldwide?

Article metrics

Helicobacter pylori eradication therapy is effective in preventing gastric cancer, even in patients with advanced pre-neoplastic lesions (gastric atrophy and/or intestinal metaplasia). We must now focus on how to accomplish the goal of eliminating gastric cancer-related death worldwide; strategies for screening and treatment of gastric neoplasia (primary prevention) and post-treatment surveillance (secondary prevention) are discussed herein.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Uemura, N. et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784–789 (2001).

  2. 2.

    Ford, A. C. et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 348, g3174 (2004).

  3. 3.

    Yoon, S. B. et al. Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter 19, 243–248 (2014).

  4. 4.

    Sugano, K. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64, 1353–1367 (2015).

  5. 5.

    Choi, I. J. et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N. Engl. J. Med. 378, 1085–1095 (2018).

  6. 6.

    Lee, Y. C. et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 62, 676–682 (2013).

  7. 7.

    Tsuda, M. et al. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan. Helicobacter 22, e12415 (2017).

  8. 8.

    Vilaichone, R. K. et al. Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J. Gastroenterol. 19, 2806–2810 (2013).

  9. 9.

    Kuo, Y. T. et al. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2, 707–715 (2017).

  10. 10.

    Rugge, M. et al. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut https://doi.org/10.1136/gutjnl-2017-314600 (2018).

Download references

Acknowledgements

The author acknowledges support from the US NIH National Institute of Diabetes and Digestive and Kidney Diseases (grant DK62813); the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant 16H05191); and from the Japan Society for the Promotion of Science (Core-to-Core Program).

Author information

Correspondence to Yoshio Yamaoka.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Related links

GLOBOCAN 2012: http://globocan.iarc.fr/

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yamaoka, Y. How to eliminate gastric cancer-related death worldwide?. Nat Rev Clin Oncol 15, 407–408 (2018) doi:10.1038/s41571-018-0029-8

Download citation

Further reading